Selected Publications

• article

  1. The Impact of Hearing Loss on Annual Incident Age-Associated Dementia Cases and Quality of Life in the US..  The journals of gerontology. Series A, Biological sciences and medical sciences.  81. 2026
  2. Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025-2026..  The New England journal of medicine.  393:2221-2242. 2025
  3. Racial Differences in Work Relative Value Units for Outpatient Pediatric Dermatology Visits..  JID innovations : skin science from molecules to population health.  5:-. 2025
  4. Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age..  JAMA dermatology.  161:274-280. 2025
  5. Projecting the Potential Clinical and Economic Impact of HIV Prevention Resource Reallocation in Tennessee..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  79:1458-1467. 2024
  6. The lifetime quality of life effects of untreated and treated hearing loss among US adults..  Journal of the American Geriatrics Society.  72:3905-3908. 2024
  7. Patient education and extracorporeal membrane oxygenation preferences of patients and providers in COVID care..  PloS one.  19:-. 2024
  8. Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review..  The Lancet. Global health.  12:e217-e225. 2024
  9. Implementation evaluation of a teledermatology virtual clinic at an academic medical center..  Implementation science communications.  4:-. 2023
  10. Potential Clinical and Economic Outcomes of Over-the-Counter Hearing Aids in the US..  JAMA otolaryngology-- head & neck surgery.  149:607-614. 2023
  11. The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder..  PloS one.  18:-. 2023
  12. Implementation Evaluation of a Teledermatology Virtual Clinic at an Academic Medical Center..  Research square.  2023
  13. Unsolicited patient images and burnout in dermatology..  Clinical and experimental dermatology.  48:127-128. 2023
  14. The Cost Utility of Nonpregnancy Laboratory Monitoring for Persons on Isotretinoin Acne Therapy..  JID innovations : skin science from molecules to population health.  3:-. 2023
  15. The Impact of Hearing Loss and Its Treatment on Health-Related Quality of Life Utility: a Systematic Review with Meta-analysis..  Journal of general internal medicine.  38:456-479. 2022
  16. Estimated Monetary Value of Future Research Clarifying Uncertainties Around the Optimal Adult Hearing Screening Schedule..  JAMA health forum.  3:-. 2022
  17. Model-Projected Cost-Effectiveness of Adult Hearing Screening in the USA..  Journal of general internal medicine.  38:978-985. 2022
  18. Validation of the Decision model of the Burden of Hearing loss Across the Lifespan (DeciBHAL) in Chile, India, and Nigeria..  EClinicalMedicine.  -. 2022
  19. Development and validation of DeciBHAL-US: A novel microsimulation model of hearing loss across the lifespan in the United States..  EClinicalMedicine.  -. 2022
  20. The disproportionate burden of electronic health record messages with image attachments in dermatology..  Journal of the American Academy of Dermatology.  86:492-494. 2021
  21. Evidence gaps in economic analyses of hearing healthcare: A systematic review..  EClinicalMedicine.  -. 2021
  22. Cost-effectiveness of universal HIV testing and treatment: where next?.  The Lancet. Global health.  9:e573-e574. 2021
  23. Cost-effectiveness and budget impact of immediate antiretroviral therapy initiation for treatment of HIV infection in Côte d'Ivoire: A model-based analysis..  PloS one.  14:-. 2019
  24. Interventions for Preventing Thromboembolic Events in Patients With Atrial Fibrillation: A Systematic Review..  Annals of internal medicine.  169:774-787. 2018
  25. Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review..  Thrombosis and haemostasis.  118:2171-2187. 2018
  26. Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India..  AIDS research and human retroviruses.  34:486-497. 2018
  27. The Clinical and Economic Impact of Attaining National HIV/AIDS Strategy Treatment Targets in the United States..  The Journal of infectious diseases.  216:798-807. 2017
  28. Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United States..  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.  65:1266-1271. 2017
  29. Do Less Harm: Evaluating HIV Programmatic Alternatives in Response to Cutbacks in Foreign Aid..  Annals of internal medicine.  167:618-629. 2017
  30. The Anticipated Clinical and Economic Effects of 90-90-90 in South Africa..  Annals of internal medicine.  165:325-33. 2016